Cowen Healthcare Investments
Venture capitalNew York · 2 people tracked
Find your way into Cowen Healthcare Investments
Fund manager profile
Cowen Healthcare Investments is a venture fund manager based in New York. SEC filings show 3 venture funds on record, most recently Cowen Healthcare Investments IV LP filed December 2022.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 2 people
from public directoriesWhat they invest in
from 10 of 11 portfolio companiesBiotech ×9Healthtech ×4AI & Machine Learning ×3Deep Tech ×2B2B Marketplaces ×1Digital Health ×1Fintech ×1Medical Devices ×1
HQs:United States×8Brazil×1
Investments · 11 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 12023 · 22022 · 32020 · 18 dated
Aktis Oncology discovers and develops targeted radiopharmaceuticals for treating solid tumors.
BiotechHealthtechMedical DevicesBoston, US
Todd Foley(Co-founder and Chairman)inPatrick Baeuerle(Co-founder & Advisor)inShulamit Ron-Bigger(Executive Officer)inKyle D. Kuvalanka(Chief Financial Officer)inAkos Czibere(Chief Medical Officer)inPaul L. Feldman(Chief Scientific Officer)in
Co-investorsAndreessen HorowitzEcoR1 CapitalMPM BioImpactMRL Ventures FundRA CapitalTCG Crossover+4 more
BiotechSan Diego, US
Alain Baron(Executive Officer, Director)JeenJoo Kang(Director)Robert Tjian(Director)Marcus Boehm(Executive Officer)
BoardAndrew Schwab(Director)in
Board seatKevin Raidy· per SEC Form D · $120M raise · filed Nov 2022
Co-investors5AM VenturesAvego BioScience CapitalNew Enterprise Associates (NEA)OUP (Osage University Partners)Sanofi VenturesThe Column Group+3 more
Akouos is a precision genetic medicine company developing therapies for the inner ear to restore, improve, and preserve hearing.
BiotechHealthtechBrookline, US
Emmanuel Simons(Executive Officer, Director)william sewell(Founder)in
BoardEd Mathers(Director)inKush Parmar(Director)in
Co-investors5AM VenturesEcoR1 CapitalNew Enterprise Associates (NEA)RA CapitalSofinnova VenturesFidelity Investments+1 more
Aro is a Brazilian technology platform that connects users with over 40 regulated credit partners to find personal loans, payroll (consignado CLT) loans, phone-collateral loans, and credit for people with negative credit records.
AI & Machine LearningB2B MarketplacesFintech
Co-investorsNorte Ventures17SigmaNorthpond VenturesOnevc Venture Partners Llc
Aro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins.
BiotechHealthtechPhiladelphia, US
Karyn O'Neil(Executive Officer, Director)Susan Dillon(Founder)inMark V. Laurenzi(Executive Officer)
BoardElizabeth Anderson(Director)Bruce Peacock(Director)
Co-investorsAvego BioScience CapitalHealthCapAgent CapitalBiotechnology Value FundJohnson & Johnson Innovation – JJDCNorthpond Ventures
Evox Therapeutics develops exosome-based gene editing therapies using its ExoEdit platform, which combines exosome delivery with a proprietary CRISPR-based editor to treat severe neurodegenerative and other genetically-driven diseases.
BiotechDeep Tech
Co-investorsOrbiMedOxford Science EnterprisesPanacea VentureGV (Google Ventures)REDMILE
Nested Therapeutics is a precision oncology company developing small-molecule cancer therapeutics by identifying overlooked driver mutations and novel binding pockets through a drug discovery platform combining genomics, computational biophysics, machine learning, and chemical biology.
AI & Machine LearningBiotechHealthtech
Arvin Dar(Co-founder & Board Observer)inKevan Shokat(Scientific Co-founder)Klaus Hoeflich(Co-founder & former Chief Scientific Officer)inDarrin Miles(Chief Executive Officer)inPhilip Komarnitsky(Chief Medical Officer)inTanja Weber(Chief Business Officer)in
Co-investorsVersant VenturesForesite CapitalSixty Degree CapitalGoldman SachsSection 32
Neuron23 is a biotech company using data science, human genetics, and functional genomics to develop precision medicines and companion diagnostics for neurodegenerative diseases, starting with an LRRK2 program for Parkinson's disease.
AI & Machine LearningBiotechDeep TechDigital HealthSouth San Francisco, US
Nancy Stagliano(CEO)in
Co-investorsKleiner PerkinsSoftBank GroupSoftBank Vision FundWestlake Village BioPartnersACORN BIOVENTURESHBM Partners+1 more
Cambridge, US
Christophe Queva(Executive Officer)inTheodore Ashburn(Executive Officer, Director)Alon Lazarus(Director)Cameron Wheeler(Director)in
BoardBriggs Morrison(Director)inMitchell Finer(Executive Officer, Director)
Co-investorsAstellas Venture Management LLCDeerfield Management CompanyMPM BioImpact
Star Therapeutics develops treatments aimed at addressing real-world patient needs.
BiotechSouth San Francisco, US
Adam Rosenthal(Founder & CEO)inNancy Stagliano(Director)inMichelle Carpenter(Executive Officer)Sandip Panicker(Executive Officer)Scott Robertson(Executive Officer)inGary Patou(Executive Officer)in
Co-investorsFrazier Life SciencesOrbiMedRA CapitalSanofi VenturesSofinnova VenturesAgent Capital+8 more
TORL BioTherapeutics is a clinical-stage biopharmaceutical company developing antibody-drug conjugates and monoclonal antibodies for cancer, including lead candidate TORL-1-23 targeting CLDN6 in ovarian cancer.
BiotechCulver City, US
Mark Alles(Executive Officer, Director)Mark Attanasio(Director)David Licata(Executive Officer, Director)Neil O'Brien(Director)Amit Sinha(Director)Lynn Seely(Director)
Co-investorsOCV PartnersRA CapitalGoldman SachsPerceptive Xontogeny VentureVertex Ventures HC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 1
1 IPOsAktis OncologyNASDAQ: AKTS
Portfolio news
latest coverage across their companiesAro · altss.com · Aug 11, 2026
Thumbnail for Escient Pharmaceuticals · wewillcure.com · May 1, 2026
Torl Bio · endpoints.news · Oct 7, 2025
Star Therapeutics · pharmaceutical-technology.com · Oct 1, 2025
Neuron23 · finsmes.com · Jun 25, 2025
Frequently asked questions
- How many investments has Cowen Healthcare Investments made?
- Cowen Healthcare Investments has 11 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
- Where is Cowen Healthcare Investments located?
- Cowen Healthcare Investments is headquartered in New York, US.